Cardinal Health Inc. recalls Xolair (omalizumab injection)
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- CGMP Deviations - Product was exposed to temperatures outside the product's labeled storage requirements.
- Products
-
- Xolair (omalizumab injection)
- Company
- Cardinal Health Inc.
- Where it was sold
-
Nationwide Within the U.S.
Nationwide
- Units affected
- 4 units
- About this recall
- Xolair (omalizumab injection), 75 mg/0.5 ml, Rx only, Genentech, Inc., South San Francisco, CA 94080, NDC 50242-214-55